Search Results for "financial"

Teresa Hagan Thomas, PhD, RN, assistant professor from the University of Pittsburgh School of Nursing sits down with ONS Staff Writer, Chris Pirschel to discuss financial toxicity and its impact on patients with cancer.

ONS’s Director of Government Affairs in Washington, DC, Alec Stone, MA, MPA, joins Chris Pirschel, ONS staff writer, to discuss the legislative efforts in play to tackle financial toxicity, how ONS is involved in the conversation, and what nurses can do to advocate for their patients facing financial burden from cancer care.

“When we’re talking about the role of nurses in addressing these challenges, they play a critical role because of when they actually get to see patients. And so, if we can help with early identification and assessment, really finding out, using financial screening tools to identify any patients that might be at risk, early on, of financial toxicity, that can really allow for timely interventions,” Sarah Paul, LCSW, OSW-C, senior director of social work at CancerCare in New York, NY, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about financial toxicity in adolescent and young adult cancer survivors.

In this third panel discussion from ONS’s Health Policy Summit in Washington DC, Alan Balch, PhD, Patient Advocate Foundation chief executive officer, Mike Ybarra, MD, FAAEM, FACEP, vice president of medical affairs for the Pharmaceutical Research Manufacturers Association, and Jeannine Walston, a 20-year brain cancer survivor and patient advocate, discuss the challenges of tackling financial toxicity from an industry perspective, how nurses can advocate for patient resources, and much more.

The inflating price tag of cancer care means that more patients are facing the difficult choice of paying for everyday needs or their cancer treatment. Matthew Banegas, PhD, MPH, MS, associate professor of radiation medicine and applied sciences at the University of California San Diego and a member of Moores Cancer Center’s Cancer Control Program, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about COVID-driven financial hardship and its implications for cancer care. Banegas presented about the topic at the 47th Annual ONS Congress in Anaheim, CA, on April 30, 2022; his session is linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes.   

In this live panel discussion from ONS’s Health Policy Summit in Washington, DC, oncology nurses Darcy Burbage, RN, MSN, AOCN®, CBC, Bobbie Khan, MS, RN, OCN®, Mary Anderson, BSN, RN, OCN®, and Nancy Corbitt BSN, RN, OCN®, CRNI, discuss treatment affordability, financial toxicity, how it’s impacting patients with cancer, and much more.

In this second live panel discussion from ONS’s Health Policy Summit in Washington, DC, Georgetown University research professor JoAnn Valk, MA, and Judith Gorsuch, JD, vice president at Hart Health Strategies, discuss the differences between private and federal coverage, the complexities of navigating cancer costs, the important Medicare information nurses need to know, and much more.

Dede Sweeney, ONS’s director of government affairs, joins Chris Pirschel, ONS staff writer, to discuss Congress’s plan to address high prescription drug costs, what the current administration is doing about it, what nurses can do to help their patients, and more.

“I was in this really unique space of being 19. So I’m over the 18 cut-off of peds but diagnosed with Ewing sarcoma, but I was an adult. I was able and supposed to be making my own decisions but treated in a pediatric setting. And not everybody in that setting is expecting to talk to someone who is educated and understands what's going on,” Alec Kupelian, a cancer survivor and operations and program development specialist at Teen Cancer America in Los Angeles, CA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about advocacy for adolescents and young adults (AYAs) with cancer and his own cancer journey.